发明公开
- 专利标题： FORMOTEROL SUPERFINE FORMULATION
-
申请号： EP19166324.4申请日： 2003-02-26
-
公开(公告)号： EP3494995A2公开(公告)日： 2019-06-12
- 发明人: DAVIES, Rebecca Jaine , GANDERTON, David , LEWIS, David Andrew , MEAKIN, Brian John , CHURCH, Tanya Kathleen , BRAMBILLA, Gaetano , FERRARIS, Alessandra
- 申请人： Chiesi Farmaceutici S.p.A.
- 申请人地址： Via Palermo, 26/A 43100 Parma IT
- 专利权人： Chiesi Farmaceutici S.p.A.
- 当前专利权人： Chiesi Farmaceutici S.p.A.
- 当前专利权人地址： Via Palermo, 26/A 43100 Parma IT
- 代理机构： Dempster, Robert Charles
- 优先权： EP02004786 20020301; EP02023589 20021023
- 主分类号： A61K47/10
- IPC分类号： A61K47/10 ; A61K31/485
摘要：
A propellant/co-solvent system comprising fully dissolved formoterol, or a stereoisomer, physiologically acceptable salt or solvate thereof, and capable of providing on actuation of a pressurized metered dose inhaler a fraction of at least 30% of emitted particles with an aerodynamic diameter equal or less than 1.1 µm for use in the treatment of a respiratory disorder selected from asthma and chronic obstructive pulmonary disease.
公开/授权文献
- EP3494995B1 FORMOTEROL SUPERFINE FORMULATION 公开/授权日：2020-02-19
信息查询
IPC分类:
